| dc.contributor.author |
Erkurt, MA |
|
| dc.contributor.author |
Berber, I |
|
| dc.contributor.author |
Tekgunduz, E |
|
| dc.contributor.author |
Dogu, MH |
|
| dc.contributor.author |
Korkmaz, S |
|
| dc.contributor.author |
Demir, C |
|
| dc.contributor.author |
Yilmaz, M |
|
| dc.contributor.author |
Akay, OM |
|
| dc.contributor.author |
Pala, C |
|
| dc.contributor.author |
Bilen, Y |
|
| dc.contributor.author |
Kaya, E |
|
| dc.contributor.author |
Sari, I |
|
| dc.contributor.author |
Sencan, M |
|
| dc.contributor.author |
Kuku, I |
|
| dc.contributor.author |
Altuntas, F |
|
| dc.contributor.author |
Dal, MS |
|
| dc.contributor.author |
Aydogdu, I |
|
| dc.date.accessioned |
2022-10-13T11:35:01Z |
|
| dc.date.available |
2022-10-13T11:35:01Z |
|
| dc.date.issued |
2016 |
|
| dc.identifier.uri |
http://hdl.handle.net/11616/78929 |
|
| dc.description.abstract |
We investigated the course of 54 patients presenting with primary central nervous system lymphoma, who were treated in daily practice. The patients were treated with chemotherapy and/or radiotherapy and/or intrathecal chemotherapy. At a median follow-up period of 23 months (range 1-71), median relapse-free survival (RFS) and overall survival (OS) were not reached. Estimated 2-year RFS and OS rates were 42% and 48%, respectively. Ten relapsed PCNSL patients underwent ASCT. Complete remission rate of these patients was 40%, with 20% treatment-related mortality. Estimated 2-year RFS and OS rates were 37% and 40%, respectively. The prognosis of patients with PCNSL, who received off-study treatment, is still dismal. (c) 2016 Elsevier Ltd. All rights reserved. |
|
| dc.description.abstract |
C1 [Erkurt, Mehmet Ali; Berber, Ilhami; Kaya, Emin; Kuku, Irfan] Inonu Univ, Fac Med, Dept Hematol, TR-44069 Malatya, Turkey. |
|
| dc.description.abstract |
[Tekgunduz, Emre; Altuntas, Fevzi; Dal, Mehmet Sinan] Ankara Oncol Hosp, Hematol & HCT Clin, Ankara, Turkey. |
|
| dc.description.abstract |
[Dogu, Mehmet Hilmi; Sari, Ismail] Pamukkale Univ, Fac Med, Dept Hematol, Denizli, Turkey. |
|
| dc.description.abstract |
[Korkmaz, Serdal] Kayseri Trainer & Res Hosp, Div Hematol, Kayseri, Turkey. |
|
| dc.description.abstract |
[Demir, Cengiz] Yuzuncu Yil Univ, Fac Med, Dept Hematol, Van, Turkey. |
|
| dc.description.abstract |
[Yilmaz, Mehmet] Antep Univ, Fac Med, Dept Hematol, Gaziantep, Turkey. |
|
| dc.description.abstract |
[Akay, Olga Meltem] Osmangazi Univ, Fac Med, Dept Hematol, Eskisehir, Turkey. |
|
| dc.description.abstract |
[Pala, Cigdem] Erciyes Univ, Fac Med, Dept Hematol, Kayseri, Turkey. |
|
| dc.description.abstract |
[Bilen, Yusuf] Ataturk Univ, Fac Med, Dept Hematol, Erzurum, Turkey. |
|
| dc.description.abstract |
[Sencan, Mehmet] Cumhuriyet Univ, Fac Med, Dept Hematol, Sivas, Turkey. |
|
| dc.description.abstract |
[Altuntas, Fevzi] Yildirim Beyazit Univ, Fac Med, Dept Internal Med, Div Hematol, Ankara, Turkey. |
|
| dc.description.abstract |
[Aydogdu, Ismet] Celal Bayar Univ, Fac Med, Dept Hematol, Manisa, Turkey. |
|
| dc.source |
TRANSFUSION AND APHERESIS SCIENCE |
|
| dc.title |
Primary central nervous system lymphoma in daily practice and the role |
|
| dc.title |
of autologous stem cell transplantation in relapsed disease: A |
|
| dc.title |
retrospective multicenter study |
|